As of 2025-09-16, the Relative Valuation of Biogen Inc (BIIB) is 181.72 USD. This relative valuation is based on P/E multiples. With the latest stock price at 143.32 USD, the upside of Biogen Inc based on Relative Valuation is 26.8%.
The range of the Relative Valuation is 154.29 - 221.32 USD.
| Range | Selected | |
| Trailing P/E multiples | 14.8x - 17.9x | 16.4x |
| Forward P/E multiples | 13.4x - 18.8x | 16.2x |
| Fair Price | 154.29 - 221.32 | 181.72 |
| Upside | 7.7% - 54.4% | 26.8% |
| Date | P/E |
| 2025-09-15 | 13.73 |
| 2025-09-12 | 13.88 |
| 2025-09-11 | 14.26 |
| 2025-09-10 | 13.66 |
| 2025-09-09 | 13.76 |
| 2025-09-08 | 13.54 |
| 2025-09-05 | 13.48 |
| 2025-09-04 | 13.41 |
| 2025-09-03 | 13.57 |
| 2025-09-02 | 13.38 |
| 2025-08-29 | 12.67 |
| 2025-08-28 | 12.71 |
| 2025-08-27 | 13.06 |
| 2025-08-26 | 13.10 |
| 2025-08-25 | 13.06 |
| 2025-08-22 | 13.34 |
| 2025-08-21 | 13.33 |
| 2025-08-20 | 13.31 |
| 2025-08-19 | 13.30 |
| 2025-08-18 | 13.02 |
| 2025-08-15 | 13.28 |
| 2025-08-14 | 12.93 |
| 2025-08-13 | 12.95 |
| 2025-08-12 | 12.35 |
| 2025-08-11 | 12.26 |
| 2025-08-08 | 12.52 |
| 2025-08-07 | 12.24 |
| 2025-08-06 | 12.39 |
| 2025-08-05 | 12.73 |
| 2025-08-04 | 12.66 |
| 2025-08-01 | 12.64 |
| 2025-07-31 | 12.26 |
| 2025-07-30 | 12.13 |
| 2025-07-29 | 12.25 |
| 2025-07-28 | 12.38 |
| 2025-07-25 | 12.60 |
| 2025-07-24 | 12.70 |
| 2025-07-23 | 12.55 |
| 2025-07-22 | 12.25 |
| 2025-07-21 | 11.75 |
| 2025-07-18 | 11.97 |
| 2025-07-17 | 12.33 |
| 2025-07-16 | 12.31 |
| 2025-07-15 | 12.21 |
| 2025-07-14 | 12.75 |
| 2025-07-11 | 12.86 |
| 2025-07-10 | 12.96 |
| 2025-07-09 | 12.74 |
| 2025-07-08 | 12.88 |
| 2025-07-07 | 12.47 |